Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

311 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Codon-specific KRAS mutations predict survival benefit of trifluridine/tipiracil in metastatic colorectal cancer.
van de Haar J, Ma X, Ooft SN, van der Helm PW, Hoes LR, Mainardi S, Pinato DJ, Sun K, Salvatore L, Tortora G, Zurlo IV, Leo S, Giampieri R, Berardi R, Gelsomino F, Merz V, Mazzuca F, Antonuzzo L, Rosati G, Stavraka C, Ross P, Rodriquenz MG, Pavarana M, Messina C, Iveson T, Zoratto F, Thomas A, Fenocchio E, Ratti M, Depetris I, Cergnul M, Morelli C, Libertini M, Parisi A, De Tursi M, Zanaletti N, Garrone O, Graham J, Longarini R, Gobba SM, Petrillo A, Tamburini E, La Verde N, Petrelli F, Ricci V, Wessels LFA, Ghidini M, Cortellini A, Voest EE, Valeri N. van de Haar J, et al. Among authors: morelli c. Nat Med. 2023 Mar;29(3):605-614. doi: 10.1038/s41591-023-02240-8. Epub 2023 Mar 2. Nat Med. 2023. PMID: 36864254 Free PMC article. Clinical Trial.
Conversion Strategy in Left-Sided RAS/BRAF Wild-Type Metastatic Colorectal Cancer Patients with Unresectable Liver-Limited Disease: A Multicenter Cohort Study.
Granieri S, Cotsoglou C, Bonomi A, Salvatore L, Filippi R, Nigro O, Gelsomino F, Zurlo IV, Depetris I, Giampieri R, Berardi R, Morelli C, De Tursi M, Roberto M, Gjoni E, Germini A, de Angelis N, Memeo R, Facciorusso A, Garrone O, Ramai D, Ghidini M, Parisi A. Granieri S, et al. Among authors: morelli c. Cancers (Basel). 2022 Nov 9;14(22):5513. doi: 10.3390/cancers14225513. Cancers (Basel). 2022. PMID: 36428606 Free PMC article.
Hydroxyapatite: an Eco-Friendly Material for Enzyme Immobilization.
Gelati L, Rabufetti M, Benaglia M, Campisi S, Gervasini A, Speranza G, Morelli CF. Gelati L, et al. Among authors: morelli cf. Chempluschem. 2024 Apr 29:e202400204. doi: 10.1002/cplu.202400204. Online ahead of print. Chempluschem. 2024. PMID: 38682248
Development and Validation of an Inflammatory Prognostic Index to Predict Outcomes in Advanced/Metastatic Urothelial Cancer Patients Receiving Immune Checkpoint Inhibitors.
Mokbel S, Baciarello G, Lavaud P, Omlin A, Calabrò F, Cathomas R, Aeppli S, Parent P, Giannatempo P, Koster KL, Appel N, Gonnet P, Angius G, Tsantoulis P, Arkenau HT, Cattrini C, Messina C, Zeghondy J, Morelli C, Loriot Y, Formica V, Patrikidou A. Mokbel S, et al. Among authors: morelli c. Cancers (Basel). 2024 Apr 11;16(8):1465. doi: 10.3390/cancers16081465. Cancers (Basel). 2024. PMID: 38672547 Free PMC article.
Longitudinal feasibility of the Montreal Cognitive Assessment (MoCA) in non-demented ALS patients.
Aiello EN, Solca F, Torre S, Colombo E, Maranzano A, De Lorenzo A, Patisso V, Treddenti M, Curti B, Morelli C, Doretti A, Verde F, Ferrucci R, Barbieri S, Ruggiero F, Priori A, Silani V, Ticozzi N, Poletti B. Aiello EN, et al. Among authors: morelli c. Eur Neurol. 2024 Apr 20. doi: 10.1159/000538828. Online ahead of print. Eur Neurol. 2024. PMID: 38643758
Effectiveness of Immunotherapy in Non-Small Cell Lung Cancer Patients with a Diagnosis of COPD: Is This a Hidden Prognosticator for Survival and a Risk Factor for Immune-Related Adverse Events?
Riondino S, Rosenfeld R, Formica V, Morelli C, Parisi G, Torino F, Mariotti S, Roselli M. Riondino S, et al. Among authors: morelli c. Cancers (Basel). 2024 Mar 22;16(7):1251. doi: 10.3390/cancers16071251. Cancers (Basel). 2024. PMID: 38610929 Free PMC article. Review.
311 results